Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome

Catheterization and Cardiovascular Interventions

Volumn 63, Issue 2, 2004, Pages 231-235

  Veselka, Josef ^a   Prochazkova, Sarka ^a   Duchoňová, Radka ^a   Bolomová Homolová, Ingrid ^a   Palenickova, Jana ^a   Tesař, David ^a   Červinka, Pavel ^a   Honěk, Tomáš ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Alcohol septal ablation; Catheterization; Hypertrophic obstructive cardiomyopathy

Indexed keywords

CREATINE KINASE MB;

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART CATHETERIZATION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE NECROSIS; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ETHANOL; FEMALE; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 4744372070     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20176     Document Type: Article

References (15)

1. Boekstegers P, Steinbigler P, Molnar A, et al. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:846-853.
2. Lakkis N, Nagueh S, Killip D, Torre G, Roberts R, Spencer W III. Nonsurgical septal reduction for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience. J Interv Cardiol 2000;13:157-159.
3. Mazur W, Nagueh SF, Lakkis NM, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 2001;103:1492-1496.
4. Nagueh S, Lakkis NM, Middleton K, et al. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999;34:1123-1128.
5. Nagueh SF, Lakkis NM, Middleton KJ, et al. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 1999;99:344-347.
6. Rovner A, Sitges M, Smith R, et al. Improvement in diastolic suction in patients with hypertrophic obstructive cardiomyopathy after septal ablation. J Am Coll Cardiol 2002;39(Suppl A):451A.
7. Ruzyllo W, Chojnowska L, Demkow M, et al. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Eur Heart J 2000;21:770-777.
8. Seggewiss H, Faber L, Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 1999;47:94-100.
9. Sigwart U. Non-surgical myocardial reduction for patients with hypertrophic obstructive cardiomyopathy. Eur Heart J 2001;3(Suppl L):L38-L42.
10. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
11. Veselka J, Honěk T. The management of hypertrophic obstructive cardiomyopathy: the role of percutaneous transluminal septal myocardial ablation. Cardiol 2000;9:327-332.
12. Faber L, Seggewiss H, Kuhn H, et al. Catheter interventional septal ablation for hypertrophic obstructive cardiomyopathy: an analysis of the follow-up data from the Registry of the German Society of Cardiology. J Am Coll Cardiol 2002;39(Suppl A):3A.
13. Faber L, Welge D, Ziemssen P, Seggewiss H, Fassbender D, Horstkotte D. Septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: an analysis of the patients with dissatisfactory intervention results. J Am Coll Cardiol 2003;41(Suppl A):145A.
14. Veselka J, Honěk T. Early remodeling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol 2003;88:27-32.
15. Lawrenz T, Lieder F, Leuner C, et al. Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: studies of infarction markers and alcohol spill over. Eur Heart J 2003;24(Suppl):556.